Dr. Patrick Lawler News Archive
August 4, 2021 —
Collaborative international clinical trials testing full-dose anticoagulation with heparin (a blood thinner) in hospitalized patients with COVID-19 has found the treatment improves survival and reduces the need for vital organ support such as mechanical ventilation in moderately ill patients
May 12, 2020 —
A large-scale international clinical trial to test whether the blood thinner heparin can help improve survival for COVID-19 patients launches this week, led by clinician-scientists from the University of Manitoba and the University Health Network.